Prostate Specific Antigens
2 clinical trials · Condition
◉ Watch Prostate Specific Antigens
| Record | Firm | Date |
|---|---|---|
| A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer (NCT00972309) | National Cancer Institute (NCI) | 2009-05-11 |
Track Prostate Specific Antigens automatically
Every clearance here is in the API, with alerts when new ones post.